Key result
Failure to routinely conduct cumulative meta-analyses may have resulted in 41,000 deaths annually from non-use of intravenous dilators, 35,000 from aspirin non-use, and 37,000 from ß-blockers non-use.
Why the study?
Living systematic review methodology was recently developed, and investigators sought to estimate the historical mortality likely resulting from the failure to use this approach.
Does the use of routine prospective cumulative systematic reviews reduce estimated historical mortality in patients with acute myocardial infarction?
Does the use of routine prospective cumulative systematic reviews reduce estimated historical mortality in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
The failure to conduct routine prospective cumulative systematic reviews historically delayed the adoption of life-saving therapies and the discontinuation of harmful ones in acute myocardial infarction.
In 1992, Antman and colleagues published a pioneering study demonstrating that knowledge of the effectiveness, ineffectiveness, or harm associated with 15 interventions to reduce mortality among patients who had suffered acute myocardial infarctions (MIs) could have improved medical practice [1]. Effective interventions could have been, but were not adopted, ineffective and harmful interventions could have been, but were not, discontinued. Effective medical practices were delayed for years-even decades because ongoing systematic reviews of the state of knowledge were not conducted as new research emerged. The methodology of "living systematic reviews" (LSR) has recently been developed for the conduct of cumulative meta-analyses. To demonstrate the benefits of this approach, we use data from the Antman study to estimate the mortality likely to have resulted from the failure to use LSR [2]. Methods We estimate mortality associated with four interventions analyzed by Antman: three interventions that reduce mortalityintravenous vasodilators administered during hospitalization, and -blockers and aspirin administered during and after hospitalization, and one intervention that increases mortality-Class 1 anti-arrhythmic drugs [1,3]. Antman's study reports the year in which cumulative meta-analysis first indicated benefit (or harm) for each intervention, and the year in which the intervention became routine in practice (or was eliminated because it was found to be ineffective or harmful) [1]. Routine practice was assessed by examination of reviews and texts focused on the intervention published each year.
No takes yet. Share an insight, caveat, or question.
Robert A. Hahn (2021) studied Acute myocardial infarction. Failure to conduct routine prospective cumulative systematic reviews vs. Conducting cumulative meta-analyses was evaluated on Estimated annual deaths attributable to non-use of effective interventions. Failure to routinely conduct cumulative meta-analyses may have resulted in 41,000 deaths annually from non-use of intravenous dilators, 35,000 from aspirin non-use, and 37,000 from ß-blockers non-use.
Synapse has enriched 10 related papers. Consider them for comparative context: